SCHEMBL18926547

SCHEMBL18926547

CCC#Cc1ccccc1C#CCOS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ KEAP1 Q14145 1/20 0.36
▸ NFE2L2 Q16236 1/20 0.36
▸ STAT3 P40763 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CA12 O43570 4/20 0.35
▸ CA9 Q16790 4/20 0.35
▸ CA2 P00918 3/20 0.35
▸ LMNA P02545 3/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ GAA P10253 2/20 0.33
▸ CA1 P00915 2/20 0.33
▸ BCHE P06276 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18934372 0.94 VDR (0.42) VDRALDH1A1KEAP1NFE2L2STAT3
SCHEMBL18926551 0.86 CA12 (0.45) ALDH1A1STAT3HTTSMN1; SMN2CA12
SCHEMBL18926553 0.84 CA12 (0.42) VDRALDH1A1STAT3HTTCA12
SCHEMBL1603835 0.84 GAA (0.41) VDRALDH1A1STAT3SMN1; SMN2CA12
SCHEMBL7572644 0.83 MEN1 (0.39) VDRALDH1A1KEAP1NFE2L2HTT
SCHEMBL6553349 0.81 CA12 (0.51) VDRALDH1A1KEAP1NFE2L2STAT3
SCHEMBL7644858 0.80 GAA (0.46) VDRALDH1A1STAT3SMN1; SMN2CA12
SCHEMBL12611117 0.80 STAT3 (0.38) VDRALDH1A1STAT3SMN1; SMN2CA12
SCHEMBL31438232 0.80 STAT3 (0.38) VDRALDH1A1STAT3SMN1; SMN2CA12
SCHEMBL7581349 0.79 CA12 (0.50) VDRALDH1A1STAT3HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170158521-A1 EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2017-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170158521-A1 EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE CD14, ERG28, DAP3 VDR 1847/4885ALDH1A1 4842/4885KEAP1 4577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback